Stem cells help stroke victims
   According to two studies published in the current issue of Cell 
 Transplantation (Vol.16 No.10), stroke victims may benefit from human 
 mesenchymal stem cell (hMSC) or bone marrow stromal cell (BMSCs) 
 transplantation. In both studies, the migration of 
 chemically "tagged" transplanted stem cells were tracked to determine 
 the degree to which the transplanted cells reached damaged areas of 
 the brain and became therapeutically active.
 
 In a study carried out by Korean researchers, labelled hMSCs (early 
 precursor cells to musculoskeletal, blood, vascular and urogenital 
 systems) were transplanted into animal stroke models with cerebral 
 artery occlusion and tracked by magnetic resonance imaging (MRI) at 
 two days, one week, two weeks, six weeks and ten weeks after 
 transplant.
 
 "Cells started showing indications of migration as early as one or 
 two weeks following transplantation,
 DPhil, of the Pochon CHA University College of Medicine. "At 10 
 weeks, the majority of the cells were detected in the core of the 
 infarcted area."
 
 The study concluded that there is a strong tendency for transplanted 
 hMSCs to migrate toward the infarcted area regardless of injection 
 site but that the degree of migration was likely based on differences 
 in each animal's ischemic condition.
 
 "We speculate that the extensive migratory nature of stem cells and 
 their utilization will provide an important tool for developing novel 
 stroke therapies," said Song.
 
 BMSCs migrate to damaged brain tissue, improve neural function
 
 In a joint Canadian, Chinese study, BMSCs - connective tissue cells - 
 were injected into animals 24 hours following middle cerebral artery 
 occlusion. Using laser scanning confocal microscopy to track 
 fluorescent signals and immuno-markers attached to the cells, 
 researchers found that within seven days of the injection the BMSCs 
 had migrated through the region of the middle cerebral artery into 
 the scar area and border zone of the ischemic region.
 
 "We evaluated vascular density in the ischemic region in all animals 
 seven days after cell transplantation,
 Li, MD, PhD. "The animals exhibited significant reductions in scar 
 size and cell death and improvements in neurological function when 
 compared to controls that received no BMSCs."
 
 Researchers concluded that the intravenous delivery of bone marrow-
 derived cells may enhance tissue repair and, in turn, functional 
 recovery after a stroke. While the potential mechanisms for this 
 recovery are unclear, among the possibilities are that the brain 
 microenvironment early on following a stroke may mimic brain 
 development. Subsequent elevated levels of growth factors might 
 enhance homing of BMSCs to the injured area and induce cell 
 proliferation.
 
 "Our results support the potential therapeutic use of BMSCs after a 
 stroke," concluded Li.
 
 Related links: Scientists use stems cells used to grow cartilage | 
 Notch effect `converts' stem cells into cells of the nervous system | 
 Korean stem cell scandal revisited | What makes a stem cell a stem 
 cell? |
  
 http://www.scientis
 victims.thtml
 
 
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Earn your degree in as few as 2 years - Advance your career with an AS, BS, MS degree - College-Finder.net.
 
 Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
 
 
 
 
 

 






 
